---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009650"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:54:10.224408+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tempus AI reports preliminary FY2025 revenue ~$1.27B (+83% YoY); TCV exceeds $1.1B

## Summary
- FY2025 revenue ~$1.27B (+83% YoY); diagnostics ~$955M (+111%), data/apps ~$316M (+31%).
- Q4 2025 revenue ~$367M (+83% YoY); diagnostics ~$266M (+121%), data/apps ~$100M (+25%).
- Record total contract value >$1.1B as of Dec 31, 2025; net revenue retention ~126%.
- Signed data agreements with >70 customers including AstraZeneca, Pfizer, Novartis, Merck, Eli Lilly, etc.
- Preliminary results subject to change; final earnings call in Feb 2026.

## SEC filing metadata
- accession: 0001193125-26-009650
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/0001193125-26-009650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/d38597d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009650
- JSON: https://secwatch.observer/filing/0001193125-26-009650.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.